Niagen Bioscience, Inc. — Director's Dealing 2010

Nov 18, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2010-11-15

Reporting Person: Spengler William (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-11-15	Common Stock	A	1000000	$0.00	Acquired	1000000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-11-15	Employee Stock Options (right to buy)	$1.65	A	58823	Acquired	2020-11-15	Common Stock (58823)	Direct
2010-11-15	Employee Stock Options (right to buy)	$1.65	A	1000000	Acquired	2020-11-15	Common Stock (1000000)	Direct
2010-11-15	Employee Stock Options (right to buy)	$1.65	A	941177	Acquired	2020-11-15	Common Stock (941177)	Direct

Footnotes

F1: Sale of restricted common stock ("Restricted Stock") of Issuer in accordance with Issuer's Second Amended and Restated 2007 Equity Incentive Plan ("2007 Equity Incentive Plan") pursuant to a Restricted Stock Agreement between Issuer and the Reporting Person. The purchase price per share is the par value ($0.001 per share) of the Restricted Stock payable in cash. The Restricted Stock vests in full on November 15, 2013 (the "Vesting Date"), provided that the Reporting Person is continuously emplyed by Issuer from November 15, 2010 (the "Effective Date") through the Vesting Date and the per share fair market value of the Issuer's common stock at any time prior to the Vesting Date shall have increased by at least three-times $1.65. The Restricted Stock is subject to further terms as set forth in the Employment Agreement, dated October 27, 2010 (the "Employment Agreement").

F2: Grant of "incentive stock option" pursuant to Issuer's 2007 Equity Incentive Plan.

F3: Options vest 25% on the first anniversary after the Effective Date and the remaining 75% vest in 36 equal installments commencing on the last day of the month following the month in which the first anniversary of the Effective Date occurs.

F4: Grant of "nonqualified stock option" pursuant to Issuer's 2007 Equity Incentive Plan.

F5: The options shall vest based on the achievement of certain milestones established by the Issuer's Compensation Committee as provided in the Employment Agreement.